EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study

Clinical trial NCT06486142 · RECRUITING

Trial details

NCT number: NCT06486142
Sponsor: Region Skane
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2022-09-21
Primary completion: 2028-09-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.